Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives

Ali Riza Cenk Celebi Atakent Education and Research Hospital, Department of Ophthalmology, Acibadem University School of Medicine, Istanbul, TurkeyCorrespondence: Ali Riza Cenk CelebiAtakent Education and Research Hospital, Department of Ophthalmology, Acibadem University School of Medicine, Istanbu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Celebi ARC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	hyperbaric oxygen therapy hbot central retinal artery occlusion crao Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/5036eca3163a4709ac1e67f79c68767d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5036eca3163a4709ac1e67f79c68767d
record_format	dspace
spelling	oai:doaj.org-article:5036eca3163a4709ac1e67f79c68767d2021-12-02T16:36:29ZHyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives1177-5483https://doaj.org/article/5036eca3163a4709ac1e67f79c68767d2021-08-01T00:00:00Zhttps://www.dovepress.com/hyperbaric-oxygen-therapy-for-central-retinal-artery-occlusion-patient-peer-reviewed-fulltext-article-OPTHhttps://doaj.org/toc/1177-5483Ali Riza Cenk Celebi Atakent Education and Research Hospital, Department of Ophthalmology, Acibadem University School of Medicine, Istanbul, TurkeyCorrespondence: Ali Riza Cenk CelebiAtakent Education and Research Hospital, Department of Ophthalmology, Acibadem University School of Medicine, Istanbul, 34303, TurkeyTel +90 212 404 40 84Email arcenkcelebi@gmail.com; cenk.celebi@acibadem.edu.trAbstract: The central retinal artery occlusion (CRAO) is a rare ophthalmological emergency that can occur in the eye. CRAO can affect persons of any age, however it is most common in people over the age of 60. CRAO is associated with a number of risk factors, including giant cell arteritis, carotid artery atherosclerosis, cardiogenic emboli, hypertension, smoking, diabetes, and thromboembolic disease. The chance of each of these etiologies being present is assessed during the course of the investigation. Hyperbaric oxygen treatment (HBOT) is classified by the American Heart Association for CRAO at level IIb. In accordance with that, HBOT might be considered for the treatment of such a severe condition. HBOT can maintain retinal oxygenation during ischemic events by allowing oxygen to diffuse through choroidal capillaries that have been exposed to elevated partial pressures of oxygen. As a result, ischemia-related damage is reversed if applied within proper time frame. The amount of time that has passed prior to initiation of HBOT is considered to be the most critical factor in determining the best visual prognosis. According to the Undersea and Hyperbaric Medical Society, patients who are identified with CRAO after the onset of symptoms should be evaluated for HBOT within 24 hours. HBOT has the advantage of having a low risk profile, and it can be utilized to improve visual outcomes in proper patients.Keywords: hyperbaric oxygen therapy, HBOT, central retinal artery occlusion, CRAOCelebi ARCDove Medical Pressarticlehyperbaric oxygen therapyhbotcentral retinal artery occlusioncraoOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 3443-3457 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	hyperbaric oxygen therapy hbot central retinal artery occlusion crao Ophthalmology RE1-994
spellingShingle	hyperbaric oxygen therapy hbot central retinal artery occlusion crao Ophthalmology RE1-994 Celebi ARC Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives
description	Ali Riza Cenk Celebi Atakent Education and Research Hospital, Department of Ophthalmology, Acibadem University School of Medicine, Istanbul, TurkeyCorrespondence: Ali Riza Cenk CelebiAtakent Education and Research Hospital, Department of Ophthalmology, Acibadem University School of Medicine, Istanbul, 34303, TurkeyTel +90 212 404 40 84Email arcenkcelebi@gmail.com; cenk.celebi@acibadem.edu.trAbstract: The central retinal artery occlusion (CRAO) is a rare ophthalmological emergency that can occur in the eye. CRAO can affect persons of any age, however it is most common in people over the age of 60. CRAO is associated with a number of risk factors, including giant cell arteritis, carotid artery atherosclerosis, cardiogenic emboli, hypertension, smoking, diabetes, and thromboembolic disease. The chance of each of these etiologies being present is assessed during the course of the investigation. Hyperbaric oxygen treatment (HBOT) is classified by the American Heart Association for CRAO at level IIb. In accordance with that, HBOT might be considered for the treatment of such a severe condition. HBOT can maintain retinal oxygenation during ischemic events by allowing oxygen to diffuse through choroidal capillaries that have been exposed to elevated partial pressures of oxygen. As a result, ischemia-related damage is reversed if applied within proper time frame. The amount of time that has passed prior to initiation of HBOT is considered to be the most critical factor in determining the best visual prognosis. According to the Undersea and Hyperbaric Medical Society, patients who are identified with CRAO after the onset of symptoms should be evaluated for HBOT within 24 hours. HBOT has the advantage of having a low risk profile, and it can be utilized to improve visual outcomes in proper patients.Keywords: hyperbaric oxygen therapy, HBOT, central retinal artery occlusion, CRAO
format	article
author	Celebi ARC
author_facet	Celebi ARC
author_sort	Celebi ARC
title	Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives
title_short	Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives
title_full	Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives
title_fullStr	Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives
title_full_unstemmed	Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives
title_sort	hyperbaric oxygen therapy for central retinal artery occlusion: patient selection and perspectives
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/5036eca3163a4709ac1e67f79c68767d
work_keys_str_mv	AT celebiarc hyperbaricoxygentherapyforcentralretinalarteryocclusionpatientselectionandperspectives
_version_	1718383632582705152

Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives

Ejemplares similares